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1. Introduction 
Early studies [ 1 ] indicate that dopamine-fl-hydroxy- 
lase was formerly believed to be associated with 
catecholamine-containing ranules in the adrenal 
medulla. However, this could only be demonstrated by 
centrifuging a large mitochondrial fraction through a 
sucrose density gradient [2--41. More recently it was 
claimed that dopamine-fl-hydroxylase was located 
partly on the exterior of the chromaffin granule 
membrane. This suggests that /3-hydroxylation might 
occur outside the granules which would mean that it 
is not necessary for the dopamine to penetrate the 
granules [5] . As these results are completely at 
variance with the concept of the structure-linked 
latency of dopamine-fl-hydroxylase [6], the present 
experiments were undertaken. 
In order to determine whether or not an enzyme 
exists in a latent form, two conditions must be 
fulfilled [7]. Firstly, the enzyme must be contained 
within a given subcellular particle. The second, and 
perhaps the most important condition is that the 
membrane of this particle must be impermeable to the 
substrate, thus preventing its penetration towards the 
enzyme. Several enzymes, such as monoamine oxidase 
and cytochrome oxidase (which, however, are mitochon- 
drial) have no latency because of the high permeability 
of mitochondrial membranes to their substrates. 
2. Methods 
Fresh bovine adrenal glands were obtained from the 
local slaughterhouse and immediately chilled in ice-cold 
0.25 M sucrose. The medullae were dissected from the 
total gland, minced and then homogenized in 10 vol of 
0.25 M sucrose with a Dual1 homogenizer. An M + L 
fraction was prepared as previously described [6]. 
After two washings, this fraction was carefully suspended 
in 20 vol of 0.25 M sucrose. 
Purified chromaffm granules were obtained by 
centrifuging an M + L fraction layered on a 1.6 M 
sucrose solution according to the method of Smith and 
Winkler [8] . 
The free activity of dopamine-fl-hydroxylase was 
measured in isotonic conditions as previously described 
[6] except that, here, catalase and tranylcypromine 
were omitted. The total activity was assayed in the 
presence of 0.05% Triton X-100. 
3. Results and discussion 
The structure-linked latency of dopamine-fl-hydroxy 
lase was estimated biochemically as the difference 
between the activity assayed under isotonic conditions, 
which tend to respect the integrity of the particles 
(free activity), and the activity determined in the 
presence of Triton X- 100, which disrupts the particle 
(total activity). Fig.1 shows both activities as obtained 
by increasing the enzyme concentration in an M + L 
fraction from bovine adrenal medulla. At low enzyme 
concentration, IV-ethylmaleimide had no effect on the 
total dopamine-@hydroxylase activity. However, the 
latter was only found to increase linearly as a function 
of enzyme concentration when IV-ethylmaleimide 
was added to the incubation mixture. Even under such 
conditions, more than 90 per cent of the total dopamine- 
P-hydroxylase was present in a latent form since the 
total activity was practically 10 times greater than the 
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Fig.1. Influence of increasing enzyme concentration on the 
free (---) and total activity ( -_) of dopamine-p-hydroxy- 
lase in an M + L fraction from bovine adrenal medulla in the 
presence (A) and the absence (0) of lo-” M N-ethylmaleimide. 
free activity. Consequently, the structure-linked latency 
of dopamine-/3-hydroxylase was not due to the presence 
of endogenous inhibitors, but to the fact that the 
membrane of chromaffm granules prevents the 
penetrations of the substrate into the granules where 
dopamine-fl-hydroxylase is normally located. The 
existence of a residual free activity (about 10% of total 
activity) must be due to damage to the granules during 
homogenization or even caused by the suspension 
pellet corresponding to the M + L fraction. 
As reported earlier [6] the structure-linked 
latency of dopamine-/I-hydroxylase disappeared after 
various activating procedures such as osmotic shock. 
A similar phenomenon was also observed when granules 
were purified by centrifuging through a 1.6 M sucrose 
solution. Fig.2 shows that the free activity of dopamine- 
fi-hydroxylase increased tremendously as compared 
with an M + L fraction, when purified granules were 
suspended in distilled water as well as in isotonic 
sucrose. Identical results were obtained by suspending 
the granules in 0.16 M or 1 M KCl. This clearly indicates 
that in the course of purification, the granules were 
disrupted by osmotic shock, and also virtually rules 
out the suggestion of Thomas et al. [5] that dopamine- 
P-hydroxylase might be bound to the exterior of 
chromaffin granule membrane. The establishment of 
the dopamine-/3-hydroxylase latency appears a valuable 
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Fig.2. The free activity of dopamine-fl-hydroxylase as a 
percentage of total activity, in an M + L fraction and in 
purified granules which were suspended in 0.25 M sucrose or 
distilled water. The enzymic activities were assayed in the 
presence or absence of lo-’ M ethylmaleimide. Results are 
the mean of six determinations with standard deviation. 
tool, and is probably the most sensitive means of 
assessing the degree of integrity or damage in a granule 
preparation. In this respect, granules from splenic 
nerves were found to be much more damaged (free 
activity ranging from 30 to 40% of total activity) than 
chromaffin granules as nerve tissues are far more difficult 
to homogenize [9]. For in vitro studies, the isolation 
procedure using Ficoll gradients in isotonic conditions 
[lo] is therefore preferable to using sucrose gradients 
PI. 
In conclusion, the foregoing data confirm our 
previous finding that dopamine-fl-hydroxylase is a 
latent enzyme and is thus readily contained on the 
inside of chromaffin granules, a feature which has been 
recently confirmed by immunological techniques [ 11 ,121. 
The endogenous inhibitors are not responsible for 
such structure-linked latency which may be attributed 
to the absence of penetration of tyramine and even 
dopamine [6] into granules. Consequently, the latency 
concept does not support the view, still a classical one, 
however, that catecholamines may diffuse from the 
cytosol into granules [ 131. On the contrary, it 
supports indirectly the idea that catecholamines [ 141 
and specifically dopamine [4] are taken up into the 
133 
Volume 52, number 1 FEBS LETTERS March 1975 
granules by an active process, the rate of which 
nevertheless is too low to influence the latency of 
dopamine-/I-hydroxylase. Conversely a diffusion of 
catecholamines from the granules to outside which 
certainly occurs under in vitro conditions presumably 
owing to the abnormal external medium, is quite 
unlikely to occur in vivo because if it were so, then the 
granules or vesicles would lose almost their entire 
catecholamine content through the axonal flow or 
cytoplasmic transport, without concomitantly releasing 
dopamine-/I-hydroxylase. Consequently, the chromaffin 
granules which behave as osmometers, may be 
considered as subcellular entities relatively independent 
and allowing the precursors of noradrenaline or 
adrenaline to cross the granule membrane only in one 
direction and by means of an active process. This view 
is entirely compatible with the structure-linked latency 
of dopamine$hydroxylase 
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